Literature DB >> 24177365

Aziridines from alkenyl-β-D-galactopyranoside derivatives: Stereoselective synthesis and in vitro selective anticancer activity.

José M Vega-Pérez1, Carlos Palo-Nieto, Margarita Vega-Holm, Purificación Góngora-Vargas, José Manuel Calderón-Montaño, Estefanía Burgos-Morón, Miguel López-Lázaro, Fernando Iglesias-Guerra.   

Abstract

A series of new aziridines β-D-galactopyranoside derivatives were synthesized from alkenyl β-D-galactopyranosides employing Sharpless conditions. The structures of the compounds were established by (1)H NMR, (13)C NMR, MS, HRMS and elemental analysis. The stereoselectivity of the reaction and the structural requirements of the alkenyl precursor for improving diastereoisomeric excesses of the direct aziridination reaction were also studied. The new compounds were subjected to a preliminary screening for cytotoxic activity against human lung cancer cells vs. human non-malignant lung cells. Terminal aziridine derivatives showed activity and, most notably, selectivity. One of the most active and selective compounds was also evaluated against breast cancer cells, melanoma cells, and non-malignant cells from the same origin. Its cytotoxic activity was similar to that of the positive controls, displaying a highly selective cytotoxic activity against both types of cancer cells.
Copyright © 2013 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Aziridine carbohydrate derivative; Cancer; Selective cytotoxic activity; Stereoselective synthesis

Mesh:

Substances:

Year:  2013        PMID: 24177365     DOI: 10.1016/j.ejmech.2013.10.020

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Two preclinical tests to evaluate anticancer activity and to help validate drug candidates for clinical trials.

Authors:  Miguel López-Lázaro
Journal:  Oncoscience       Date:  2015-02-20

2.  In Vitro Anticancer Activity and Mechanism of Action of an Aziridinyl Galactopyranoside.

Authors:  Estefanía Burgos-Morón; Nuria Pastor; Manuel Luis Orta; Julio José Jiménez-Alonso; Carlos Palo-Nieto; Margarita Vega-Holm; José Manuel Vega-Pérez; Fernando Iglesias-Guerra; Santiago Mateos; Miguel López-Lázaro; José Manuel Calderón-Montaño
Journal:  Biomedicines       Date:  2021-12-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.